Department of Prenatal Diagnostic, Jiaxing Maternity and Children Health Care Hospital, Jiaxing University, Jiaxing, Zhejiang, China.
J Int Med Res. 2020 May;48(5):300060520918061. doi: 10.1177/0300060520918061.
This study investigated micro (mi)RNAs associated with the survival of patients with gallbladder carcinoma (GBC).
miRNA expression profiling was carried out of 40 cancerous tissues from GBC patients with long-term (n = 20) and short-term (n = 20) survival and eight healthy gallbladder tissues from the Gene Expression Omnibus database. miRNAs dysregulated in GBC patients with long-term or short-term survival were identified using GEO2R and VennDiagram packages, and analyzed by miRNA target prediction tools and the clusterProfiler package.
Compared with healthy gallbladder tissues, 104 and 124 miRNAs were dysregulated in cancerous tissues of GBC patients with long-term survival and short-term survival, respectively. Two miRNAs (hsa-miR-142-5p and hsa-miR-146b-5p) and 22 miRNAs (such as hsa-miR-30a-3p, hsa-miR-660-5p, and hsa-miR-338-3p) were exclusively dysregulated in GBC patients with long-term and short-term survival, respectively. Enrichment analysis revealed that miRNAs exclusively dysregulated in GBC patients with short-term survival were involved in 46 biological processes, 10 cellular components, 11 molecular functions, and 44 pathways such as morphogenesis of an epithelium, response to transforming growth factor beta, heterochromatin, and phosphatase binding.
This study not only identified some promising biomarkers for predicting survival in GBC patients, but also contributed to our understanding of the pathogenesis and prognosis of GBC.
本研究旨在探讨与胆囊癌(GBC)患者生存相关的微小 RNA(miRNA)。
从 GEO 数据库中获取 40 例 GBC 患者癌组织(长期生存组 n=20,短期生存组 n=20)和 8 例正常胆囊组织的 miRNA 表达谱数据。使用 GEO2R 和 VennDiagram 软件包筛选出 GBC 患者长期和短期生存中差异表达的 miRNA,并用 miRNA 靶基因预测工具和 clusterProfiler 软件包进行分析。
与正常胆囊组织相比,长期生存和短期生存的 GBC 患者癌组织中分别有 104 个和 124 个 miRNA 表达失调。两个 miRNA(hsa-miR-142-5p 和 hsa-miR-146b-5p)和 22 个 miRNA(如 hsa-miR-30a-3p、hsa-miR-660-5p 和 hsa-miR-338-3p)分别在长期和短期生存的 GBC 患者中特异性失调。富集分析表明,短期生存的 GBC 患者中特异性失调的 miRNA 涉及 46 个生物学过程、10 个细胞成分、11 个分子功能和 44 条途径,如上皮形态发生、转化生长因子-β反应、异染色质和磷酸酶结合。
本研究不仅鉴定了一些有前途的预测 GBC 患者生存的生物标志物,还为我们理解 GBC 的发病机制和预后提供了帮助。